{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:48:09Z","timestamp":1768009689717,"version":"3.49.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HL149318"],"award-info":[{"award-number":["HL149318"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["CA172408"],"award-info":[{"award-number":["CA172408"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HL145883"],"award-info":[{"award-number":["HL145883"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41375-025-02803-3","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T11:00:50Z","timestamp":1763377250000},"page":"166-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncogenic activation of EVC\/EVC2 defines a therapeutically targetable subset of acute myeloid leukemia"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3779-9592","authenticated-orcid":false,"given":"Pinpin","family":"Sui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3308-906X","authenticated-orcid":false,"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juyeong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline R.","family":"Delma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3394-6922","authenticated-orcid":false,"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songmi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6734-994X","authenticated-orcid":false,"given":"Asra","family":"Noor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakun","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1778-9071","authenticated-orcid":false,"given":"Yu","family":"Luan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7063-6253","authenticated-orcid":false,"given":"Mingjiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4537-9638","authenticated-orcid":false,"given":"Jihoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8524-4095","authenticated-orcid":false,"given":"Feng-Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"2803_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood-2015-10-662684","volume":"127","author":"B Lowenberg","year":"2016","unstructured":"Lowenberg B, Rowe JM. Introduction to the review series on advances in acute myeloid leukemia (AML). Blood. 2016;127:1.","journal-title":"Blood"},{"key":"2803_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.10","volume":"2","author":"A Khwaja","year":"2016","unstructured":"Khwaja A, Bjorkholm M, Gale RE, Levine RL, Jordan CT, Ehninger G, et al. Acute myeloid leukaemia. Nat Rev Dis Prim. 2016;2:16010.","journal-title":"Nat Rev Dis Prim"},{"key":"2803_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1182\/blood-2015-08-604520","volume":"127","author":"H Dombret","year":"2016","unstructured":"Dombret H, Gardin C. An update of current treatments for adult acute myeloid leukemia. Blood. 2016;127:53\u201361.","journal-title":"Blood"},{"key":"2803_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.gde.2016.03.011","volume":"36","author":"S Li","year":"2016","unstructured":"Li S, Mason CE, Melnick A. Genetic and epigenetic heterogeneity in acute myeloid leukemia. Curr Opin Genet Dev. 2016;36:100\u20136.","journal-title":"Curr Opin Genet Dev"},{"key":"2803_CR5","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209\u201321.","journal-title":"N Engl J Med"},{"key":"2803_CR6","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","volume":"28","author":"AGX Zeng","year":"2022","unstructured":"Zeng AGX, Bansal S, Jin L, Mitchell A, Chen WC, Abbas HA, et al. A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia. Nat Med. 2022;28:1212\u201323.","journal-title":"Nat Med"},{"key":"2803_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1300874","volume":"369","author":"F Lo-Coco","year":"2013","unstructured":"Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013;369:111\u201321.","journal-title":"N Engl J Med"},{"key":"2803_CR8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","volume":"383","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, et al. Azacitidine and Venetoclax in previously untreated acute myeloid leukemia. N Engl J Med. 2020;383:617\u201329.","journal-title":"N Engl J Med"},{"key":"2803_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1182\/blood.2019002140","volume":"135","author":"GJ Roboz","year":"2020","unstructured":"Roboz GJ, DiNardo CD, Stein EM, de Botton S, Mims AS, Prince GT, et al. Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia. Blood. 2020;135:463\u201371.","journal-title":"Blood"},{"key":"2803_CR10","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1056\/NEJMoa1902688","volume":"381","author":"AE Perl","year":"2019","unstructured":"Perl AE, Martinelli G, Cortes JE, Neubauer A, Berman E, Paolini S, et al. Gilteritinib or chemotherapy for relapsed or refractory FLT3-Mutated AML. N Engl J Med. 2019;381:1728\u201340.","journal-title":"N Engl J Med"},{"key":"2803_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMoa1614359","volume":"377","author":"RM Stone","year":"2017","unstructured":"Stone RM, Mandrekar SJ, Sanford BL, Laumann K, Geyer S, Bloomfield CD, et al. Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation. N Engl J Med. 2017;377:454\u201364.","journal-title":"N Engl J Med"},{"key":"2803_CR12","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1056\/NEJMoa031046","volume":"350","author":"L Bullinger","year":"2004","unstructured":"Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med. 2004;350:1605\u201316.","journal-title":"N Engl J Med"},{"key":"2803_CR13","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","volume":"364","author":"R Bejar","year":"2011","unstructured":"Bejar R, Stevenson K, Abdel-Wahab O, Galili N, Nilsson B, Garcia-Manero G, et al. Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med. 2011;364:2496\u2013506.","journal-title":"N Engl J Med"},{"key":"2803_CR14","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1038\/leu.2009.141","volume":"23","author":"N Carbuccia","year":"2009","unstructured":"Carbuccia N, Murati A, Trouplin V, Brecqueville M, Adelaide J, Rey J, et al. Mutations of ASXL1 gene in myeloproliferative neoplasms. Leukemia. 2009;23:2183\u20136.","journal-title":"Leukemia"},{"key":"2803_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-8722-5-12","volume":"5","author":"V Gelsi-Boyer","year":"2012","unstructured":"Gelsi-Boyer V, Brecqueville M, Devillier R, Murati A, Mozziconacci MJ, Birnbaum D. Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases. J Hematol Oncol. 2012;5:12.","journal-title":"J Hematol Oncol"},{"key":"2803_CR16","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","volume":"145","author":"V Gelsi-Boyer","year":"2009","unstructured":"Gelsi-Boyer V, Trouplin V, Adelaide J, Bonansea J, Cervera N, Carbuccia N, et al. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol. 2009;145:788\u2013800.","journal-title":"Br J Haematol"},{"key":"2803_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2022.106910","volume":"120","author":"PV Lipilkin","year":"2022","unstructured":"Lipilkin PV, Kulaeva ED, Mashkina EV. Prognostic value of ASXL1 mutations in acute myeloid leukemia: a meta-analysis. Leuk Res. 2022;120:106910.","journal-title":"Leuk Res"},{"key":"2803_CR18","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","volume":"366","author":"JP Patel","year":"2012","unstructured":"Patel JP, Gonen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med. 2012;366:1079\u201389.","journal-title":"N Engl J Med"},{"key":"2803_CR19","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/ng.3400","volume":"47","author":"E Stieglitz","year":"2015","unstructured":"Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, et al. The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2015;47:1326\u201333.","journal-title":"Nat Genet"},{"key":"2803_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.exphem.2015.11.011","volume":"44","author":"D Inoue","year":"2016","unstructured":"Inoue D, Matsumoto M, Nagase R, Saika M, Fujino T, Nakayama KI, et al. Truncation mutants of ASXL1 observed in myeloid malignancies are expressed at detectable protein levels. Exp Hematol. 2016;44:172\u20136.e1.","journal-title":"Exp Hematol"},{"key":"2803_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1046\/j.1365-2141.1999.01377.x","volume":"106","author":"JR Downing","year":"1999","unstructured":"Downing JR. The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: biology and clinical significance. Br J Haematol. 1999;106:296\u2013308.","journal-title":"Br J Haematol"},{"key":"2803_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood.V86.1.1.bloodjournal8611","volume":"86","author":"G Nucifora","year":"1995","unstructured":"Nucifora G, Rowley JD. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood. 1995;86:1\u201314.","journal-title":"Blood"},{"key":"2803_CR23","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1038\/s41388-021-01952-w","volume":"40","author":"K Rejeski","year":"2021","unstructured":"Rejeski K, Duque-Afonso J, Lubbert M. AML1\/ETO and its function as a regulator of gene transcription via epigenetic mechanisms. Oncogene. 2021;40:5665\u201376.","journal-title":"Oncogene"},{"key":"2803_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-1445-0","volume":"16","author":"DJ Trombly","year":"2015","unstructured":"Trombly DJ, Whitfield TW, Padmanabhan S, Gordon JA, Lian JB, van Wijnen AJ, et al. Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells. BMC Genom. 2015;16:309.","journal-title":"BMC Genom"},{"key":"2803_CR25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ccr.2007.04.010","volume":"11","author":"Y Liu","year":"2007","unstructured":"Liu Y, Chen W, Gaudet J, Cheney MD, Roudaia L, Cierpicki T, et al. Structural basis for recognition of SMRT\/N-CoR by the MYND domain and its contribution to AML1\/ETO\u2019s activity. Cancer Cell. 2007;11:483\u201397.","journal-title":"Cancer Cell"},{"key":"2803_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/73508","volume":"24","author":"VL Ruiz-Perez","year":"2000","unstructured":"Ruiz-Perez VL, Ide SE, Strom TM, Lorenz B, Wilson D, Woods K, et al. Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet. 2000;24:283\u20136.","journal-title":"Nat Genet"},{"key":"2803_CR27","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1086\/368063","volume":"72","author":"VL Ruiz-Perez","year":"2003","unstructured":"Ruiz-Perez VL, Tompson SW, Blair HJ, Espinoza-Valdez C, Lapunzina P, Silva EO, et al. Mutations in two nonhomologous genes in a head-to-head configuration cause Ellis-van Creveld syndrome. Am J Hum Genet. 2003;72:728\u201332.","journal-title":"Am J Hum Genet"},{"key":"2803_CR28","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/cr.2012.134","volume":"22","author":"C Yang","year":"2012","unstructured":"Yang C, Chen W, Chen Y, Jiang J. Smoothened transduces Hedgehog signal by forming a complex with Evc\/Evc2. Cell Res. 2012;22:1593\u2013604.","journal-title":"Cell Res"},{"key":"2803_CR29","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1242\/dev.007542","volume":"134","author":"VL Ruiz-Perez","year":"2007","unstructured":"Ruiz-Perez VL, Blair HJ, Rodriguez-Andres ME, Blanco MJ, Wilson A, Liu YN, et al. Evc is a positive mediator of Ihh-regulated bone growth that localises at the base of chondrocyte cilia. Development. 2007;134:2903\u201312.","journal-title":"Development"},{"key":"2803_CR30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.devcel.2012.10.001","volume":"23","author":"J Eggenschwiler","year":"2012","unstructured":"Eggenschwiler J. Hedgehog signaling and the cilium: in the zone. Dev Cell. 2012;23:677\u20138.","journal-title":"Dev Cell"},{"key":"2803_CR31","doi-asserted-by":"crossref","unstructured":"Jeng KS, Sheen IS, Leu CM, Tseng PH, Chang CF. The role of smoothened in cancer. Int J Mol Sci. 2020;21:6863.","DOI":"10.3390\/ijms21186863"},{"key":"2803_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"2803_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166\u20139.","journal-title":"Bioinformatics"},{"key":"2803_CR34","doi-asserted-by":"crossref","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. 2005;102:15545\u201350.","DOI":"10.1073\/pnas.0506580102"},{"key":"2803_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"2803_CR36","doi-asserted-by":"publisher","first-page":"W11","DOI":"10.1093\/nar\/gky504","volume":"46","author":"J Wolff","year":"2018","unstructured":"Wolff J, Bhardwaj V, Nothjunge S, Richard G, Renschler G, Gilsbach R, et al. Galaxy HiCExplorer: a web server for reproducible Hi-C data analysis, quality control and visualization. Nucleic Acids Res. 2018;46:W11\u20136.","journal-title":"Nucleic Acids Res"},{"key":"2803_CR37","doi-asserted-by":"publisher","first-page":"e1012067","DOI":"10.1371\/journal.pcbi.1012067","volume":"20","author":"N Abdennur","year":"2024","unstructured":"Open2C, Abdennur N, Abraham S, Fudenberg G, Flyamer IM, Galitsyna AA, et al. Cooltools: enabling high-resolution Hi-C analysis in Python. PLoS Comput Biol. 2024;20:e1012067.","journal-title":"PLoS Comput Biol"},{"key":"2803_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cels.2016.07.002","volume":"3","author":"NC Durand","year":"2016","unstructured":"Durand NC, Shamim MS, Machol I, Rao SS, Huntley MH, Lander ES, et al. Juicer provides a one-click system for analyzing loop-resolution Hi-C experiments. Cell Syst. 2016;3:95\u20138.","journal-title":"Cell Syst"},{"key":"2803_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17239-9","volume":"11","author":"TJ Salameh","year":"2020","unstructured":"Salameh TJ, Wang X, Song F, Zhang B, Wright SM, Khunsriraksakul C, et al. A supervised learning framework for chromatin loop detection in genome-wide contact maps. Nat Commun. 2020;11:3428.","journal-title":"Nat Commun"},{"key":"2803_CR40","doi-asserted-by":"crossref","unstructured":"Ge G, Zhang P, Sui P, Chen S, Yang H, Guo Y, et al. Targeting lysine demethylase 6B ameliorates ASXL1 truncation-mediated myeloid malignancies in preclinical models. J Clin Investig. 2024;134:e163964.","DOI":"10.1172\/JCI163964"},{"key":"2803_CR41","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.3646","volume":"48","author":"MR Corces","year":"2016","unstructured":"Corces MR, Buenrostro JD, Wu B, Greenside PG, Chan SM, Koenig JL, et al. Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution. Nat Genet. 2016;48:1193\u2013203.","journal-title":"Nat Genet"},{"key":"2803_CR42","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","volume":"40","author":"D Bottomly","year":"2022","unstructured":"Bottomly D, Long N, Schultz AR, Kurtz SE, Tognon CE, Johnson K, et al. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia. Cancer Cell. 2022;40:850\u201364.e9.","journal-title":"Cancer Cell"},{"key":"2803_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-03031-7","volume":"24","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Jiang S, He F, Tian Y, Hu H, Gao L, et al. Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML. Genome Biol. 2023;24:199.","journal-title":"Genome Biol"},{"key":"2803_CR44","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.molcel.2020.12.005","volume":"81","author":"KR Stengel","year":"2021","unstructured":"Stengel KR, Ellis JD, Spielman CL, Bomber ML, Hiebert SW. Definition of a small core transcriptional circuit regulated by AML1-ETO. Mol Cell. 2021;81:530\u201345.e5.","journal-title":"Mol Cell"},{"key":"2803_CR45","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"Cancer","year":"2013","unstructured":"Cancer, Genome, Atlas, Research N, Ley TJ, Miller C, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059\u201374.","journal-title":"N Engl J Med"},{"key":"2803_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nm.4439","volume":"24","author":"H Bolouri","year":"2018","unstructured":"Bolouri H, Farrar JE, Triche T Jr, Ries RE, Lim EL, Alonzo TA, et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat Med. 2018;24:103\u201312.","journal-title":"Nat Med"},{"key":"2803_CR47","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1182\/blood-2017-06-789669","volume":"131","author":"H Yang","year":"2018","unstructured":"Yang H, Kurtenbach S, Guo Y, Lohse I, Durante MA, Li J, et al. Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies. Blood. 2018;131:328\u201341.","journal-title":"Blood"},{"key":"2803_CR48","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1182\/blood-2013-05-500272","volume":"123","author":"J Wang","year":"2014","unstructured":"Wang J, Li Z, He Y, Pan F, Chen S, Rhodes S, et al. Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice. Blood. 2014;123:541\u201353.","journal-title":"Blood"},{"key":"2803_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccr.2012.06.032","volume":"22","author":"O Abdel-Wahab","year":"2012","unstructured":"Abdel-Wahab O, Adli M, LaFave LM, Gao J, Hricik T, Shih AH, et al. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell. 2012;22:180\u201393.","journal-title":"Cancer Cell"},{"key":"2803_CR50","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1084\/jem.20131141","volume":"210","author":"O Abdel-Wahab","year":"2013","unstructured":"Abdel-Wahab O, Gao J, Adli M, Dey A, Trimarchi T, Chung YR, et al. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. J Exp Med. 2013;210:2641\u201359.","journal-title":"J Exp Med"},{"key":"2803_CR51","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.molcel.2020.04.018","volume":"78","author":"X Zhang","year":"2020","unstructured":"Zhang X, Jeong M, Huang X, Wang XQ, Wang X, Zhou W, et al. Large DNA methylation nadirs anchor chromatin loops maintaining hematopoietic stem cell identity. Mol Cell. 2020;78:506\u201321.e6.","journal-title":"Mol Cell"},{"key":"2803_CR52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2201883119","volume":"119","author":"K Kraft","year":"2022","unstructured":"Kraft K, Yost KE, Murphy SE, Magg A, Long Y, Corces MR, et al. Polycomb-mediated genome architecture enables long-range spreading of H3K27 methylation. Proc Natl Acad Sci USA. 2022;119:e2201883119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2803_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1021658","volume":"10","author":"Y Guo","year":"2022","unstructured":"Guo Y, Wang GG. Modulation of the high-order chromatin structure by Polycomb complexes. Front Cell Dev Biol. 2022;10:1021658.","journal-title":"Front Cell Dev Biol"},{"key":"2803_CR54","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.devcel.2012.07.004","volume":"23","author":"KV Dorn","year":"2012","unstructured":"Dorn KV, Hughes CE, Rohatgi R. A Smoothened-Evc2 complex transduces the Hedgehog signal at primary cilia. Dev Cell. 2012;23:823\u201335.","journal-title":"Dev Cell"},{"key":"2803_CR55","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.stem.2009.03.016","volume":"4","author":"Hofmann","year":"2009","unstructured":"Hofmann, Stover I, Cullen DE EH, Mao J, Morgan KJ, Lee BH, et al. Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell. 2009;4:559\u201367.","journal-title":"Cell Stem Cell"},{"key":"2803_CR56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41375-018-0312-9","volume":"33","author":"JE Cortes","year":"2019","unstructured":"Cortes JE, Heidel FH, Hellmann A, Fiedler W, Smith BD, Robak T, et al. Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome. Leukemia. 2019;33:379\u201389.","journal-title":"Leukemia"},{"key":"2803_CR57","doi-asserted-by":"crossref","unstructured":"Lin I, Wei A, Awamleh Z, Singh M, Ning A, Herrera A, et al. Multiomics of Bohring-Opitz syndrome truncating ASXL1 mutations identify canonical and noncanonical Wnt signaling dysregulation. JCI Insight. 2023;8:e167744.","DOI":"10.1172\/jci.insight.167744"},{"key":"2803_CR58","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/ajmg.a.62156","volume":"185","author":"VA Cuddapah","year":"2021","unstructured":"Cuddapah VA, Dubbs HA, Adang L, Kugler SL, McCormick EM, Zolkipli-Cunningham Z, et al. Understanding the phenotypic spectrum of ASXL-related disease: Ten cases and a review of the literature. Am J Med Genet A. 2021;185:1700\u201311.","journal-title":"Am J Med Genet A"},{"key":"2803_CR59","unstructured":"Russell B, Tan WH, Graham JM Jr. Bohring-Opitz Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Amemiya A. editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle, 1993. [cited 2018 Feb 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK481833\/."},{"key":"2803_CR60","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ejhg.2010.234","volume":"19","author":"R Hastings","year":"2011","unstructured":"Hastings R, Cobben JM, Gillessen-Kaesbach G, Goodship J, Hove H, Kjaergaard S, et al. Bohring-Opitz (Oberklaid-Danks) syndrome: clinical study, review of the literature, and discussion of possible pathogenesis. Eur J Hum Genet. 2011;19:513\u20139.","journal-title":"Eur J Hum Genet"},{"key":"2803_CR61","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1172\/JCI121366","volume":"128","author":"P Zhang","year":"2018","unstructured":"Zhang P, He F, Bai J, Yamamoto S, Chen S, Zhang L, et al. Chromatin regulator Asxl1 loss and Nf1 haploinsufficiency cooperate to accelerate myeloid malignancy. J Clin Investig. 2018;128:5383\u201398.","journal-title":"J Clin Investig"},{"key":"2803_CR62","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41588-023-01640-3","volume":"56","author":"M Umeda","year":"2024","unstructured":"Umeda M, Ma J, Westover T, Ni Y, Song G, Maciaszek JL, et al. A new genomic framework to categorize pediatric acute myeloid leukemia. Nat Genet. 2024;56:281\u201393.","journal-title":"Nat Genet"},{"key":"2803_CR63","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1756-8722-7-18","volume":"7","author":"R Tibes","year":"2014","unstructured":"Tibes R, Mesa RA. Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies. J Hematol Oncol. 2014;7:18.","journal-title":"J Hematol Oncol"},{"key":"2803_CR64","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3389\/fgene.2019.00711","volume":"10","author":"M Pelullo","year":"2019","unstructured":"Pelullo M, Zema S, Nardozza F, Checquolo S, Screpanti I, Bellavia D. Wnt, Notch, and TGF-beta pathways impinge on hedgehog signaling complexity: an open window on cancer. Front Genet. 2019;10:711.","journal-title":"Front Genet"},{"key":"2803_CR65","first-page":"1703","volume":"7","author":"D Liu","year":"2012","unstructured":"Liu D, Wang S, Cui Y, Shen L, Du Y, Li G, et al. Sonic hedgehog elevates N-myc gene expression in neural stem cells. Neural Regen Res. 2012;7:1703\u20138.","journal-title":"Neural Regen Res"},{"key":"2803_CR66","doi-asserted-by":"crossref","unstructured":"Nguyen NM, Cho J. Hedgehog pathway inhibitors as targeted cancer therapy and strategies to overcome drug resistance. Int J Mol Sci. 2022;23:1733.","DOI":"10.3390\/ijms23031733"},{"key":"2803_CR67","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.exphem.2016.08.009","volume":"44","author":"M Singh","year":"2016","unstructured":"Singh M, Chaudhry P, Merchant AA. Primary cilia are present on human blood and bone marrow cells and mediate Hedgehog signaling. Exp Hematol. 2016;44:1181\u20137.e2.","journal-title":"Exp Hematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02803-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02803-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02803-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:04:53Z","timestamp":1767985493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02803-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2803"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02803-3","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments in this study were conducted in accordance with the National Institutes of Health\u2019s guidelines on animal care and use. Experiment protocols were approved by the Institutional Animal Care and Use Committee of the University of Texas Health Science Center at San Antonio. All animals received humane care in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (National Academies Press, 2011).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}